Over the last few years, notifying bodies have been pushing for more patient-centric and diverse clinical studies. One way to ensure that a patient’s voice is heard is through clinical outcome assessments (COAs), a scientific instrument/measure whose primary function is to gather a participant’s experience subjectively instead of the biometric data gathered at site visits.
In addition, COAs also work to inform sponsors and primary investigators of the efficacy and safety of the study drug. As noted, with the adoption of remote studies, teams have begun incorporating electronic clinical outcomes assessments (eCOAs) as a tool in Primary Endpoint Studies. This has reportedly been instrumental in centering patient feedback. According to Deloitte, members of 70% of patient groups in ongoing trials are leveraging one or more apps to monitor their condition and report results.
Discover the benefits of leveraging an electronic modality to gather patient data and the overwhelming support for the use of electronic patient-reported outcomes (ePRO) over paper ones.